Tsukada F, Sugawara M, Sawamura K, Ohuchi Y, Kohno H, Ohkubo Y
Department of Radiopharmacy, Tohoku Pharmaceutical University, Sendai, Japan.
Biol Pharm Bull. 2001 Sep;24(9):995-7. doi: 10.1248/bpb.24.995.
We have reported that acute restraint stress inhibits small intestinal motility in rats. In order to clarify this inhibitory mechanism, we examined the effects of alpha- and beta-adrenergic antagonists on the inhibition of small intestinal motility induced by restraint stress. This inhibition underwent recovery by propranolol (beta1/beta2-antagonist) or SR59230A (beta3-antagonist), but not by atenolol (beta1-antagonist), ICI-118,551 (beta2-antagonist), prazosin (alpha1-antagonist) or yohimbine (alpha2-antagonist). These results suggest that beta3-adrenoceptors play an important role in the inhibition of small intestinal motility caused by restraint stress.